nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—Neurological impairment—Methotrexate—esophageal cancer	0.203	0.203	CcSEcCtD
Prilocaine—Apprehension—Cisplatin—esophageal cancer	0.0666	0.0666	CcSEcCtD
Prilocaine—Extravasation—Carboplatin—esophageal cancer	0.0499	0.0499	CcSEcCtD
Prilocaine—Neurological symptom—Cisplatin—esophageal cancer	0.0423	0.0423	CcSEcCtD
Prilocaine—Arachnoiditis—Methotrexate—esophageal cancer	0.0384	0.0384	CcSEcCtD
Prilocaine—Hypoaesthesia oral—Capecitabine—esophageal cancer	0.0361	0.0361	CcSEcCtD
Prilocaine—Hypoxemia—Methotrexate—esophageal cancer	0.0349	0.0349	CcSEcCtD
Prilocaine—Neurotoxicity—Cisplatin—esophageal cancer	0.033	0.033	CcSEcCtD
Prilocaine—Neurotoxicity—Capecitabine—esophageal cancer	0.0243	0.0243	CcSEcCtD
Prilocaine—Paraesthesia oral—Capecitabine—esophageal cancer	0.0201	0.0201	CcSEcCtD
Prilocaine—Neurotoxicity—Methotrexate—esophageal cancer	0.0181	0.0181	CcSEcCtD
Prilocaine—Extravasation—Cisplatin—esophageal cancer	0.0146	0.0146	CcSEcCtD
Prilocaine—Dysarthria—Cisplatin—esophageal cancer	0.0135	0.0135	CcSEcCtD
Prilocaine—Pain—Carboplatin—esophageal cancer	0.0133	0.0133	CcSEcCtD
Prilocaine—Neuropathy—Cisplatin—esophageal cancer	0.012	0.012	CcSEcCtD
Prilocaine—Hypoxia—Methotrexate—esophageal cancer	0.011	0.011	CcSEcCtD
Prilocaine—Paralysis—Methotrexate—esophageal cancer	0.0101	0.0101	CcSEcCtD
Prilocaine—Dysarthria—Capecitabine—esophageal cancer	0.00996	0.00996	CcSEcCtD
Prilocaine—Cyanosis—Methotrexate—esophageal cancer	0.00991	0.00991	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.00958	0.00958	CcSEcCtD
Prilocaine—Depressed level of consciousness—Capecitabine—esophageal cancer	0.00909	0.00909	CcSEcCtD
Prilocaine—Neuropathy—Capecitabine—esophageal cancer	0.00884	0.00884	CcSEcCtD
Prilocaine—Extravasation—Methotrexate—esophageal cancer	0.00804	0.00804	CcSEcCtD
Prilocaine—Swelling—Capecitabine—esophageal cancer	0.00775	0.00775	CcSEcCtD
Prilocaine—Dysarthria—Methotrexate—esophageal cancer	0.00741	0.00741	CcSEcCtD
Prilocaine—Respiratory failure—Methotrexate—esophageal cancer	0.00714	0.00714	CcSEcCtD
Prilocaine—Neuropathy peripheral—Cisplatin—esophageal cancer	0.00701	0.00701	CcSEcCtD
Prilocaine—Cardiac failure—Capecitabine—esophageal cancer	0.00701	0.00701	CcSEcCtD
Prilocaine—Osteoarthritis—Capecitabine—esophageal cancer	0.00684	0.00684	CcSEcCtD
Prilocaine—Diplopia—Capecitabine—esophageal cancer	0.00684	0.00684	CcSEcCtD
Prilocaine—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00677	0.00677	CcSEcCtD
Prilocaine—Bradycardia—Cisplatin—esophageal cancer	0.00653	0.00653	CcSEcCtD
Prilocaine—Cardiac arrest—Capecitabine—esophageal cancer	0.0065	0.0065	CcSEcCtD
Prilocaine—Tinnitus—Cisplatin—esophageal cancer	0.00598	0.00598	CcSEcCtD
Prilocaine—Bronchospasm—Capecitabine—esophageal cancer	0.00581	0.00581	CcSEcCtD
Prilocaine—Arrhythmia—Cisplatin—esophageal cancer	0.00573	0.00573	CcSEcCtD
Prilocaine—Vision blurred—Cisplatin—esophageal cancer	0.00526	0.00526	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.00526	0.00526	CcSEcCtD
Prilocaine—Tremor—Cisplatin—esophageal cancer	0.00523	0.00523	CcSEcCtD
Prilocaine—Neuropathy peripheral—Capecitabine—esophageal cancer	0.00516	0.00516	CcSEcCtD
Prilocaine—Anaemia—Cisplatin—esophageal cancer	0.00516	0.00516	CcSEcCtD
Prilocaine—Osteoarthritis—Methotrexate—esophageal cancer	0.00509	0.00509	CcSEcCtD
Prilocaine—Bradycardia—Capecitabine—esophageal cancer	0.00481	0.00481	CcSEcCtD
Prilocaine—Anxiety—Cisplatin—esophageal cancer	0.00474	0.00474	CcSEcCtD
Prilocaine—Hypoaesthesia—Capecitabine—esophageal cancer	0.00471	0.00471	CcSEcCtD
Prilocaine—Anaphylactic shock—Cisplatin—esophageal cancer	0.00456	0.00456	CcSEcCtD
Prilocaine—Oedema—Cisplatin—esophageal cancer	0.00456	0.00456	CcSEcCtD
Prilocaine—Nervous system disorder—Cisplatin—esophageal cancer	0.00447	0.00447	CcSEcCtD
Prilocaine—Tinnitus—Capecitabine—esophageal cancer	0.00441	0.00441	CcSEcCtD
Prilocaine—Hyperhidrosis—Cisplatin—esophageal cancer	0.00441	0.00441	CcSEcCtD
Prilocaine—Hypotension—Cisplatin—esophageal cancer	0.00426	0.00426	CcSEcCtD
Prilocaine—Arrhythmia—Capecitabine—esophageal cancer	0.00422	0.00422	CcSEcCtD
Prilocaine—Paraesthesia—Cisplatin—esophageal cancer	0.00409	0.00409	CcSEcCtD
Prilocaine—Drowsiness—Methotrexate—esophageal cancer	0.00392	0.00392	CcSEcCtD
Prilocaine—Pain—Cisplatin—esophageal cancer	0.0039	0.0039	CcSEcCtD
Prilocaine—Vision blurred—Capecitabine—esophageal cancer	0.00388	0.00388	CcSEcCtD
Prilocaine—Tremor—Capecitabine—esophageal cancer	0.00386	0.00386	CcSEcCtD
Prilocaine—Anaemia—Capecitabine—esophageal cancer	0.00381	0.00381	CcSEcCtD
Prilocaine—Sweating—Methotrexate—esophageal cancer	0.00376	0.00376	CcSEcCtD
Prilocaine—Feeling abnormal—Cisplatin—esophageal cancer	0.00376	0.00376	CcSEcCtD
Prilocaine—Syncope—Capecitabine—esophageal cancer	0.00369	0.00369	CcSEcCtD
Prilocaine—Loss of consciousness—Capecitabine—esophageal cancer	0.00362	0.00362	CcSEcCtD
Prilocaine—Hypertension—Capecitabine—esophageal cancer	0.00355	0.00355	CcSEcCtD
Prilocaine—Anxiety—Capecitabine—esophageal cancer	0.00349	0.00349	CcSEcCtD
Prilocaine—Confusional state—Capecitabine—esophageal cancer	0.00339	0.00339	CcSEcCtD
Prilocaine—Oedema—Capecitabine—esophageal cancer	0.00336	0.00336	CcSEcCtD
Prilocaine—Hypersensitivity—Cisplatin—esophageal cancer	0.00336	0.00336	CcSEcCtD
Prilocaine—Shock—Capecitabine—esophageal cancer	0.00331	0.00331	CcSEcCtD
Prilocaine—Nervous system disorder—Capecitabine—esophageal cancer	0.0033	0.0033	CcSEcCtD
Prilocaine—Tinnitus—Methotrexate—esophageal cancer	0.00328	0.00328	CcSEcCtD
Prilocaine—Asthenia—Cisplatin—esophageal cancer	0.00327	0.00327	CcSEcCtD
Prilocaine—Hyperhidrosis—Capecitabine—esophageal cancer	0.00325	0.00325	CcSEcCtD
Prilocaine—Hypotension—Capecitabine—esophageal cancer	0.00314	0.00314	CcSEcCtD
Prilocaine—Paraesthesia—Capecitabine—esophageal cancer	0.00302	0.00302	CcSEcCtD
Prilocaine—Vomiting—Cisplatin—esophageal cancer	0.0029	0.0029	CcSEcCtD
Prilocaine—Vision blurred—Methotrexate—esophageal cancer	0.00289	0.00289	CcSEcCtD
Prilocaine—Pain—Capecitabine—esophageal cancer	0.00287	0.00287	CcSEcCtD
Prilocaine—Anaemia—Methotrexate—esophageal cancer	0.00283	0.00283	CcSEcCtD
Prilocaine—Feeling abnormal—Capecitabine—esophageal cancer	0.00277	0.00277	CcSEcCtD
Prilocaine—Nausea—Cisplatin—esophageal cancer	0.00271	0.00271	CcSEcCtD
Prilocaine—Urticaria—Capecitabine—esophageal cancer	0.00267	0.00267	CcSEcCtD
Prilocaine—Confusional state—Methotrexate—esophageal cancer	0.00252	0.00252	CcSEcCtD
Prilocaine—Anaphylactic shock—Methotrexate—esophageal cancer	0.0025	0.0025	CcSEcCtD
Prilocaine—Hypersensitivity—Capecitabine—esophageal cancer	0.00248	0.00248	CcSEcCtD
Prilocaine—Nervous system disorder—Methotrexate—esophageal cancer	0.00245	0.00245	CcSEcCtD
Prilocaine—Hyperhidrosis—Methotrexate—esophageal cancer	0.00242	0.00242	CcSEcCtD
Prilocaine—Asthenia—Capecitabine—esophageal cancer	0.00241	0.00241	CcSEcCtD
Prilocaine—Hypotension—Methotrexate—esophageal cancer	0.00234	0.00234	CcSEcCtD
Prilocaine—Paraesthesia—Methotrexate—esophageal cancer	0.00225	0.00225	CcSEcCtD
Prilocaine—Somnolence—Methotrexate—esophageal cancer	0.00222	0.00222	CcSEcCtD
Prilocaine—Dizziness—Capecitabine—esophageal cancer	0.00222	0.00222	CcSEcCtD
Prilocaine—Pain—Methotrexate—esophageal cancer	0.00214	0.00214	CcSEcCtD
Prilocaine—Vomiting—Capecitabine—esophageal cancer	0.00214	0.00214	CcSEcCtD
Prilocaine—Feeling abnormal—Methotrexate—esophageal cancer	0.00206	0.00206	CcSEcCtD
Prilocaine—Nausea—Capecitabine—esophageal cancer	0.002	0.002	CcSEcCtD
Prilocaine—Urticaria—Methotrexate—esophageal cancer	0.00199	0.00199	CcSEcCtD
Prilocaine—Hypersensitivity—Methotrexate—esophageal cancer	0.00184	0.00184	CcSEcCtD
Prilocaine—Asthenia—Methotrexate—esophageal cancer	0.00179	0.00179	CcSEcCtD
Prilocaine—Dizziness—Methotrexate—esophageal cancer	0.00165	0.00165	CcSEcCtD
Prilocaine—Vomiting—Methotrexate—esophageal cancer	0.00159	0.00159	CcSEcCtD
Prilocaine—Nausea—Methotrexate—esophageal cancer	0.00149	0.00149	CcSEcCtD
